India's growing participation in global clinical trials

[摘要]：Lower operational costs, recent regulatory reforms and several logistic advantages make India an attractive destination for conducting clinical trials. Efforts for maintaining stringent ethical standards and the launch of Pharmacovigilance Program of India are expected to maximize the potential of the country for clinical research.

[全文传递流程]：

一般上传文献全文的时限在1个工作日内